Anuh Pharma Ltd.
Snapshot View

View in App

Prices View details >>

79.54 +0.11 ▲0.1%

24 March 2023, 04:01:00 PM
Volume: 20,253

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.anuhpharma.com
Market Cap 398.59 Cr.
Enterprise Value(EV) 394.62 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 7.08 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 11.23 Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 46.19 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.72 Calculated using Price: 79.54
Dividend Yield 2.20 Period Ending 2022-03
No. of Shares Subscribed 5.01 Cr. 50,112,000 Shares
FaceValue 5
Company Profile
Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.14%
1 Week
-1.29%
1 Month
-6.04%
3 Month
-12.11%
6 Month
-14.56%
1 Year
-13.45%
2 Year
-16.62%
5 Year
+2.66%
10 Year
+294.54%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 21.78 23.55 23.44 15.43 11.38 14.87 8.75 16.12 15.11
Return on Capital Employed (%) 32.94 35.13 34.91 21.61 16.31 20.56 10.87 19.75 19.33
Return on Assets (%) 11.75 13.29 14.37 10.58 8.35 10.44 5.06 8.63 8.99

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 86 101 119 141 150 165 162 191 214 222
Non Curr. Liab. 1 0 0 0 0 0 1 3 3 2
Curr. Liab. 77 67 72 47 59 75 163 139 131 114
Minority Int.
Equity & Liab. 163 168 191 187 208 239 326 333 347 338
Non Curr. Assets 22 24 40 50 54 87 103 95 88 90
Curr. Assets 142 144 151 138 154 152 223 238 259 248
Misc. Exp. not W/O
Total Assets 163 168 191 187 208 239 326 333 347 338

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 266 284 326 206 238 321 307 432 487 499
Other Income 4 5 4 8 7 5 4 11 5 6
Total Income 271 289 330 214 245 325 311 443 492 505
Total Expenditure -242 -253 -289 -183 -220 -291 -284 -387 -439 -448
PBIDT 28 36 41 30 26 35 27 56 53 57
Interest -1 -1 -1 -1 0 -1 -1 -2 -2 0
Depreciation -2 -3 -2 -2 -2 -2 -7 -15 -12 -10
Taxation -8 -10 -12 -8 -7 -9 -5 -10 -9 -11
Exceptional Items
PAT 18 22 26 20 17 23 14 28 31 35
Adjusted EPS 4 4 5 4 3 5 3 6 6 7

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 2 15 19 17 26 2 7 49 -19 29
Cash Fr. Inv. 4 -5 -12 -5 -20 2 3 -77 52 -8
Cash Fr. Finan. -6 -8 -8 -9 -4 -5 -7 22 -33 -19
Net Change 0 2 -1 2 2 -1 3 -5 0 2
Cash & Cash Eqvt 0 2 1 3 5 4 7 2 2 4

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 70.46 70.47 70.43 70.43 70.45 70.43 70.58 70.58 70.58
Public 29.54 29.53 29.57 29.57 29.55 29.57 29.42 29.42 29.42
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 17 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Unaudited Financial Results for the quarter ended 31.12.2022Please find enclosed herewith the copy of newspaper advertisement with respect to theUnaudited Financial Results for the quarter ended December 31 2022 published in theFinancial Express and Mumbai Lakshadeep in compliance with Regulation 47 of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.Kindly acknowledge the receipt and take the same on record.Thanking you
Fri, 17 Feb 2023
Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation - Q3 FY2023Dear Sir/Madam We are enclosing herewith our Companys Investor Presentation for Q3 FY2023.Kindly take the same on record.Thanking you
Fri, 10 Feb 2023
Submission Of Unaudited Financial Results For The Quarter Ended December 31 2022 Along With Limited Review Report.
Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended we are enclosing herewith the following:

1. Unaudited Financial Results for the quarter ended December 31 2022; and

2. Limited Review Report for the quarter ended December 31 2022.

You are requested to kindly take the same on record.

Technical Scans View Details >>

Fri, 24 Mar 2023
High Delivery Percentage High Delivery Percentage
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,570.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,317.23 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,428.40 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,367.56 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Anuh Pharma Ltd.

What is Anuh Pharma share price?
Can I buy Anuh Pharma shares now?
What is the Dividend Yield of Anuh Pharma?
What is the Market Cap of Anuh Pharma?
What are the key metrics to analyse Anuh Pharma?
What is the 52 Week High and Low of Anuh Pharma?
What is the trend of Anuh Pharma share price?